KOMIPHARM

Live / Registered — International registration cancelled — extension of protection cancelled (as of 09 May 2025)

What this means for you

Registered since 22 Nov 2016. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
79172263
Registration number
5084132
Mark type
Stylized text
Filed
08 May 2015
Published for opposition
06 Sept 2016
Registered
22 Nov 2016
Attorney of record
Yoon S. Ham

Goods and services

  • Class 005 — Pharmaceuticals: Disinfectants for hygiene purposes; Veterinary preparations, namely, pain relief medication, medication for treatment of intestinal bacteria, antioxidants; Deodorizing preparations for household, commercial or industrial use for pet litter boxes, carpets; Household deodorant; Insecticides; Germicides; Insect repellents; Medicines for veterinary purposes, namely, medicines for treatment of porcine circoviral disease, porcine epidemic diarrhea, transmissible gastroenteritis, rotavirus infection pasteurellosis, pleuropneumoniae, classical swine fever, swine erysipelas, swine mycoplasmoses, akabane disease, pasteurellosis, colibacillosis, bovine ephemeral fever, newcastle disease, infectious bronchitis, low pathogenicity avian influenza, infectious bursal disease, salmonellosis, rabies, canine distemper, infectious canine hepatitis, parvovirus infection, coronavirus infection, leptospirosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Antibiotic preparations; Chemotherapeutics; Tumor suppressing agents; Pharmaceutical preparations acting on the central nervous system; Cardiovascular pharmaceutical preparations; Pharmaceutical agents affecting metabolism; Chemical preparations for pharmaceutical purposes, namely, for the treatment of pain and inflammation associated with cancer, the treatment of cancer, the treatment of leukemia and lymphoma, the treatment of metastatic neoplastic diseases, the treatment of brain tumors, cancer stem cell-targeted and drug resistant cancer therapy, the treatment of urogenital cancer and its metastasis; Biological preparations for the treatment of porcine circoviral disease, porcine epidemic diarrhea, transmissible gastroenteritis, rotavirus infection pasteurellosis, pleuropneumoniae, classical swine fever, swine erysipelas, swine mycoplasmoses, akabane disease, pasteurellosis, colibacillosis, bovine ephemeral fever, newcastle disease, infectious bronchitis, low pathogenicity avian influenza, infectious bursal disease, salmonellosis, rabies, canine distemper, infectious canine hepatitis, parvovirus infection, coronavirus infection, leptospirosis

Owner

Prosecution history

  • 30 Nov 2025 — NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
  • 30 Nov 2025 — DEATH OF INTERNATIONAL REGISTRATION
  • 23 May 2025 — NEW REPRESENTATIVE AT IB RECEIVED
  • 11 Mar 2024 — TOTAL INVALIDATION PROCESSED BY THE IB
  • 20 Feb 2024 — TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
  • 19 Feb 2024 — INVALIDATION PROCESSED
  • 09 Feb 2024 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
  • 09 Jun 2023 — CANCELLED SECTION 71
  • 22 Nov 2021 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
  • 25 Mar 2017 — FINAL DECISION TRANSACTION PROCESSED BY IB
  • 07 Mar 2017 — FINAL DISPOSITION NOTICE SENT TO IB
  • 07 Mar 2017 — FINAL DISPOSITION PROCESSED
  • 22 Feb 2017 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
  • 22 Nov 2016 — REGISTERED-PRINCIPAL REGISTER
  • 16 Sept 2016 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

View this trademark record on Marksy